• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Behavioral problems continue into adolescence for patients with cerebral palsy

bys25qthea
October 29, 2012
in Neurology, Pediatrics, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: CC 

Key study points:

1. 36.9% of adolescents with cerebral palsy (CP) had co-existing behavioral problems, the most common being peer problems. There was evidence that behavioral problems diminished slightly with age.

2. Greater prosocial behaviors were associated with higher IQ, greater motor abilities (both gross and fine), and attendance at an integrated school.

3. Only 16.1% of the adolescents sampled had received psychological services.

Primer: CP is an umbrella term that refers to motor impairment resulting from a discrete brain insult occurring in utero, during delivery, or in the neonatal period. Behavioral problems are known to commonly co-exist in children with CP who are below 12 years of age, present in about 35% to 40%. These include hyperactivity, inattention, aggressiveness, antisocial behavior, emotional lability, and difficulties with peer relationships. However, there has been no formal evaluation of whether these behavioral concerns continue into adolescence. This study is the first to consider behavioral difficulties in adolescents with CP;

Background reading:

RELATED REPORTS

Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes

1. Brossard-Racine M, Hall N, Majnemer A, et al. Behavioural problems in school age children with cerebral palsy. Eur J Paediatr Neurol. 2012;16:35–41.

2. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8-14.

This [cross-sectional ] study surveyed 160 adolescents (mean age 15.4 ± 2.17 years; range 12-19 years) with CP and their parents; information about patients’ motor and cognitive abilities (including IQ), functional status, parental stress levels, and behavioral problems was collected. Overall, 36.9% of the adolescents had behavioral problems, with peer problems being most common (61.9%). Other problems included emotional symptoms (34.4%), conduct problems (21.3%), hyperactivity (20.0%), and lack of prosocial behaviors (15.6%). Adolescents displaying hyperactive symptoms had greater functional limitations. Younger adolescents showed a greater risk for behavioral difficulties than older adolescents, particularly for emotional symptoms, conduct problems, and hyperactivity. Having a higher IQ and attending an integrated school was associated with more prosocial behaviors and less hyperactive behavior. Higher prosocial behavior score was consistently associated with better motor performance. Only 16.1% of the adolescents sampled had received psychological services; the study raises the need for greater psychosocial interventions for this population.

In sum: Just over a third of adolescents with CP have co-existing behavioral problems, which mirrors the proportion that have difficulties in these domains as children. However, there was evidence that emotional symptoms, conduct problems, and hyperactivity diminished somewhat over the spectrum of ages sampled (12- to 19-year-olds). Greater prosocial behaviors were associated with higher IQ, greater motor abilities (both gross and fine), and attendance at an integrated school. This was a cross-sectional study that established interesting correlations, but without directionality.

Click to read the study in [Journal of Child Neurology]

 By [DB]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

 

Previous Post

Medical-legal partnerships effectively identify and treat patterns of substandard housing

Next Post

Conventional Wnt signaling pathway is a potential new target for glaucoma therapeutics

RelatedReports

Galcanezumab reduces the frequency of episodic cluster headaches
Chronic Disease

Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans

July 4, 2022
Stem cell transplant may be effective in sickle cell disease
Chronic Disease

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

July 4, 2022
New genetic link in pulmonary arterial hypertension holds therapeutic promise
Oncology

Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes

July 4, 2022
Oncology

FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option

July 4, 2022
Next Post

Conventional Wnt signaling pathway is a potential new target for glaucoma therapeutics

Treatment of liver metastases in colorectal cancer with radiofrequency ablation (RFA) show efficacy in improving long-term survival

Oseltamivir treats avian flu early

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans
  • Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality
  • Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.